Your browser doesn't support javascript.
loading
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
Bond, Katherine; Nicholson, Suellen; Lim, Seok Ming; Karapanagiotidis, Theo; Williams, Eloise; Johnson, Douglas; Hoang, Tuyet; Sia, Cheryll; Purcell, Damian; Mordant, Francesca; Lewin, Sharon R; Catton, Mike; Subbarao, Kanta; Howden, Benjamin P; Williamson, Deborah A.
Afiliação
  • Bond K; Department of Microbiology, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Nicholson S; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Lim SM; Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Karapanagiotidis T; Department of General Medicine and Infectious Diseases, Royal Melbourne Hospital, Melbourne, Australia.
  • Williams E; Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Johnson D; Department of Microbiology, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Hoang T; Department of General Medicine and Infectious Diseases, Royal Melbourne Hospital, Melbourne, Australia.
  • Sia C; Department of General Medicine, The University of Melbourne, Melbourne, Australia.
  • Purcell D; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Mordant F; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Lewin SR; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Catton M; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Subbarao K; The Peter Doherty Institute for Infection and Immunity, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia.
  • Howden BP; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.
  • Williamson DA; Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
J Infect Dis ; 222(8): 1280-1288, 2020 09 14.
Article em En | MEDLINE | ID: mdl-32761124
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: J Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: J Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos